EDOC News and Press, Global X Telemedicine & Digital Health ETF From 08/03/22

A convergence of technologies is set to revolutionize how physicians examine the body for signs of cancer. there is every reason to expect that future evolution of robotic endoluminal procedures could include the ability during the procedure to treat the cancer, either via ablation or...

Per capita U.S. healthcare spending went from $2,968 in 1980 to $12,531 in 2020 (both in 2020 dollars), more than a threefold increase. Amazon announced its plans to acquire primary healthcare company One Medical for $3.9 billion. I believe this deal represents the catalyst for a sign...

After a difficult first half, healthcare’s defensive capabilities are coming into question, but it outperformed the broader markets on a relative basis. The MSCI World Healthcare Index fell by 10.3% through June 30, 2022, in US dollar terms, compared to a 20.5% decline for the ...

Massive short interest buildup is like tinder for a bullish fire. Good economic news is the match for the short-covering rally. Healthcare stocks look especially good and should outperform. After several tortuous weeks of abnormal volatility and a directionless trading e...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips According to the Global X Telemedicine & Digital Health (NASDAQ: EDOC ) website, the global telehealth market grew by 35% in 2020 to more than $55 billion . By 2028, it’s projected to reach $300 bil...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Even the best telehealth stocks have been smashed hard this year for two reasons. First, they’re typically high-beta assets, meaning they’ve experienced excess sensitivity to 2022’s bear market. And se...

As companies adjust to inflation, rising interest rates, and a likely economic slowdown, investors are struggling to compute future earnings and the impact on stock valuations. Broadening the sources of stability can help diversify risk and return potential. Geopolitical risk and ...

Teladoc has failed to recover from the guidance shock in 1Q-22. Sales growth slowed at a scary pace in 1Q-22, suggesting that guidance risks have increased. Teladoc’s stock remains hopelessly overvalued. Teladoc Health, Inc. ( TDOC ) is experiencing a sign...

Why the economy, practically speaking, may already be in recession. Why defensive sectors may be worth a closer look in the current environment. Market sentiment might be bearish, but that doesn't mean there aren't opportunities. Aggressive moves by central banks...

Teladoc is officially a value stock, trading at a price-to-book discount. Impairment losses dealt a big blow to investors. However, operating performance can't be doubted. The company is growing its market share in the telehealth space by acquiring hypergrowth companies that provi...